Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
Objective: to study the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases type II inhibitors and ability of imatinib to enhance GISTs sensitivity to the chemotherapeutic drugs indicated above.Subjects and Methods. We studied the sensitivity of gastrointestinal stromal tumo...
Saved in:
Main Authors: | S. V. Boichuk, A. R. Galembikova, B. R. Ramazanov, A. Duensing |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-06-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal stromal tumors
by: A. P. Seryakov
Published: (2010-08-01) -
The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors
by: Huade Huo, et al.
Published: (2025-07-01) -
Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance
by: Xian-Hao Xiao, et al.
Published: (2025-07-01) -
Postoperative Cure for Metastatic Gastrointestinal Stromal Tumor
by: Eun Hyea Park, et al.
Published: (2018-12-01) -
Imatinib and hypophosphatemia: Case report and review of literature
by: Erdem Şen, et al.
Published: (2017-07-01)